发布求助
文献互助 智能选刊 最新文献

La Revue du praticien最新文献

筛选
英文 中文
[Consensus on pulmonary hypertension]. 【关于肺动脉高压的共识】。
La Revue du praticien Pub Date : 2025-01-01
Marc Humbert, Gérald Simonneau, Marion Delcroix
{"title":"[Consensus on pulmonary hypertension].","authors":"Marc Humbert, Gérald Simonneau, Marion Delcroix","doi":"","DOIUrl":"","url":null,"abstract":"","PeriodicalId":94123,"journal":{"name":"La Revue du praticien","volume":"75 1","pages":"3"},"PeriodicalIF":0.0,"publicationDate":"2025-01-01","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"","citationCount":null,"resultStr":null,"platform":"Semanticscholar","paperid":"144236253","PeriodicalName":null,"FirstCategoryId":null,"ListUrlMain":null,"RegionNum":0,"RegionCategory":"","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":"","EPubDate":null,"PubModel":null,"JCR":null,"JCRName":null,"Score":null,"Total":0}
引用次数: 0
[Proof of a surgeon's liability]. [外科医生的责任证明]。
La Revue du praticien Pub Date : 2025-01-01
Didier Guével
{"title":"[Proof of a surgeon's liability].","authors":"Didier Guével","doi":"","DOIUrl":"","url":null,"abstract":"","PeriodicalId":94123,"journal":{"name":"La Revue du praticien","volume":"75 1","pages":"19"},"PeriodicalIF":0.0,"publicationDate":"2025-01-01","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"","citationCount":null,"resultStr":null,"platform":"Semanticscholar","paperid":"144236260","PeriodicalName":null,"FirstCategoryId":null,"ListUrlMain":null,"RegionNum":0,"RegionCategory":"","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":"","EPubDate":null,"PubModel":null,"JCR":null,"JCRName":null,"Score":null,"Total":0}
引用次数: 0
[Zosteriform skin metastases]. 带状虫状皮肤转移。
La Revue du praticien Pub Date : 2025-01-01
Youssef Almheirat, Sara Bensalem, Houda Talbi, Nassiba Zarrouki, Siham Dikhaye, Nada Zizi
{"title":"[Zosteriform skin metastases].","authors":"Youssef Almheirat, Sara Bensalem, Houda Talbi, Nassiba Zarrouki, Siham Dikhaye, Nada Zizi","doi":"","DOIUrl":"","url":null,"abstract":"","PeriodicalId":94123,"journal":{"name":"La Revue du praticien","volume":"75 1","pages":"70"},"PeriodicalIF":0.0,"publicationDate":"2025-01-01","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"","citationCount":null,"resultStr":null,"platform":"Semanticscholar","paperid":"144236270","PeriodicalName":null,"FirstCategoryId":null,"ListUrlMain":null,"RegionNum":0,"RegionCategory":"","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":"","EPubDate":null,"PubModel":null,"JCR":null,"JCRName":null,"Score":null,"Total":0}
引用次数: 0
[Living with… pancreatic cancer]. [与…胰腺癌生活在一起]。
La Revue du praticien Pub Date : 2025-01-01
Sarah Baudry, François Duval, Aurélien Lambert
{"title":"[Living with… pancreatic cancer].","authors":"Sarah Baudry, François Duval, Aurélien Lambert","doi":"","DOIUrl":"","url":null,"abstract":"","PeriodicalId":94123,"journal":{"name":"La Revue du praticien","volume":"75 1","pages":"72-74"},"PeriodicalIF":0.0,"publicationDate":"2025-01-01","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"","citationCount":null,"resultStr":null,"platform":"Semanticscholar","paperid":"144236258","PeriodicalName":null,"FirstCategoryId":null,"ListUrlMain":null,"RegionNum":0,"RegionCategory":"","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":"","EPubDate":null,"PubModel":null,"JCR":null,"JCRName":null,"Score":null,"Total":0}
引用次数: 0
[Pulmonary hypertension due to left heart disease]. 【左心所致肺动脉高压】。
La Revue du praticien Pub Date : 2025-01-01
Charles Fauvel, Bouchra Lamia, Nicolas Lamblin
{"title":"[Pulmonary hypertension due to left heart disease].","authors":"Charles Fauvel, Bouchra Lamia, Nicolas Lamblin","doi":"","DOIUrl":"","url":null,"abstract":"<p><p>PULMONARY HYPERTENSION DUE TO LEFT HEART DISEASE. Pulmonary hypertension due to left heart disease (PH-LHD) is the leading cause of PH worldwide and is associated with poor short to long-term survival. Its diagnosis (mean pulmonary artery pressure > 20 mmHg with pulmonary artery wedge pressure > 15 mmHg) requires right heart catheterization at rest and afterwards, isolated post-capillary PH (RVP lower 2 WU) has to be separated from combined pre- and post-capillary PH (RVP ≥ 2 WU). Pulmonary vasodilator therapies are not indicated in PH-LHD (grade III) and the main goal is to optimize left heart disease treatment (i.e., heart failure with preserved or reduced ejection fraction or valvular heart disease).</p>","PeriodicalId":94123,"journal":{"name":"La Revue du praticien","volume":"75 1","pages":"50-55"},"PeriodicalIF":0.0,"publicationDate":"2025-01-01","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"","citationCount":null,"resultStr":null,"platform":"Semanticscholar","paperid":"144236262","PeriodicalName":null,"FirstCategoryId":null,"ListUrlMain":null,"RegionNum":0,"RegionCategory":"","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":"","EPubDate":null,"PubModel":null,"JCR":null,"JCRName":null,"Score":null,"Total":0}
引用次数: 0
[Treatment of psoriatic arthritis]. 【治疗银屑病关节炎】。
La Revue du praticien Pub Date : 2025-01-01
Clementina LópezMedina, Laure Gossec
{"title":"[Treatment of psoriatic arthritis].","authors":"Clementina LópezMedina, Laure Gossec","doi":"","DOIUrl":"","url":null,"abstract":"<p><p>TREATMENT OF PSORIATIC ARTHRITIS. Psoriatic arthritis is a chronic inflammatory rheumatic disease with a heterogeneous clinical presentation, combining peripheral arthritis and skin psoriasis, and frequently enthesitis and dactylitis. The treatment of peripheral arthritis is based on anti-inflammatory drugs, conventional disease-modifying drugs such as methotrexate, and if the disease remains active, targeted disease-modifying drugs (biotherapies, or targeted synthetic drugs). The management of psoriatic arthritis combines treatment of the joints, treatment of the skin psoriasis, and global measures such as physical therapy, patient therapeutic education and lifestyle changes (avoidance of smoking and obesity).</p>","PeriodicalId":94123,"journal":{"name":"La Revue du praticien","volume":"75 1","pages":"7-12"},"PeriodicalIF":0.0,"publicationDate":"2025-01-01","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"","citationCount":null,"resultStr":null,"platform":"Semanticscholar","paperid":"144236267","PeriodicalName":null,"FirstCategoryId":null,"ListUrlMain":null,"RegionNum":0,"RegionCategory":"","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":"","EPubDate":null,"PubModel":null,"JCR":null,"JCRName":null,"Score":null,"Total":0}
引用次数: 0
[Chronic thromboembolic pulmonary hypertension]. 慢性血栓栓塞性肺动脉高压。
La Revue du praticien Pub Date : 2025-01-01
Thomas Lacoste-Palasset, Mitja Jevnikar, Xavier Jaïs
{"title":"[Chronic thromboembolic pulmonary hypertension].","authors":"Thomas Lacoste-Palasset, Mitja Jevnikar, Xavier Jaïs","doi":"","DOIUrl":"","url":null,"abstract":"<p><p>CHRONIC THROMBOEMBOLIC PULMONARY HYPERTENSION. Chronic thromboembolic pulmonary hypertension (CTEPH) typically develops after one or more acute pulmonary embolisms (PE). Screening with echocardiography and ventilation-perfusion lung scan is recommended in cases of persistent dyspnea following PE, especially if risk factors for CTEPH are present. However, CTEPH is most often diagnosed during the evaluation of PH. Diagnostic confirmation requires right heart catheterization, which must demonstrate the presence of PH and imaging examinations (CT pulmonary angiography and/or conventional pulmonary angiography) that must reveal characteristic chronic thromboembolic lesions. In addition to effective anticoagulation, which is recommended for all patients, the choice of treatment depends on the location of pulmonary arterial obstructions, the severity of pulmonary hemodynamics, and the presence or absence of comorbidities. Treatment options include pulmonary endarterectomy, medical therapy, and balloon pulmonary angioplasty.</p>","PeriodicalId":94123,"journal":{"name":"La Revue du praticien","volume":"75 1","pages":"60-64"},"PeriodicalIF":0.0,"publicationDate":"2025-01-01","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"","citationCount":null,"resultStr":null,"platform":"Semanticscholar","paperid":"144236252","PeriodicalName":null,"FirstCategoryId":null,"ListUrlMain":null,"RegionNum":0,"RegionCategory":"","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":"","EPubDate":null,"PubModel":null,"JCR":null,"JCRName":null,"Score":null,"Total":0}
引用次数: 0
[Revised definition and classification of pulmonary hypertension]. [修订了肺动脉高压的定义和分类]。
La Revue du praticien Pub Date : 2025-01-01
Benoît Lechartier, Étienne-Marie Jutant, David Montani
{"title":"[Revised definition and classification of pulmonary hypertension].","authors":"Benoît Lechartier, Étienne-Marie Jutant, David Montani","doi":"","DOIUrl":"","url":null,"abstract":"<p><p>REVISED DEFINITION AND CLASSIFICATION OF PULMONARY HYPERTENSION. Pulmonary hypertension (PH) is a manifestation of a diverse group of diseases characterised by elevated mean pulmonary artery pressure (mPAP), measured by right heart catheterisation. The European Society of Cardiology (ESC) and European Respiratory Society (ERS) guidelines for the diagnosis and treatment of pulmonary hypertension, published in 2022, propose a new haemodynamic definition of PH by lowering the threshold for mPAP to 20 mmHg. Precapillary PH is now defined as mPAP > 20 mmHg associated with normal pulmonary artery wedge pressure (≤ 15 mmHg) and increased pulmonary vascular resistance (> 2 Wood units). These criteria were endorsed during the 7th World Symposium on Pulmonary Hypertension in 2024. The 2022 ESC/ERS guidelines also include a revision of the clinical classification of PH, maintaining the distinction between five entities based on the underlying pathophysiology.</p>","PeriodicalId":94123,"journal":{"name":"La Revue du praticien","volume":"75 1","pages":"32-35"},"PeriodicalIF":0.0,"publicationDate":"2025-01-01","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"","citationCount":null,"resultStr":null,"platform":"Semanticscholar","paperid":"144236264","PeriodicalName":null,"FirstCategoryId":null,"ListUrlMain":null,"RegionNum":0,"RegionCategory":"","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":"","EPubDate":null,"PubModel":null,"JCR":null,"JCRName":null,"Score":null,"Total":0}
引用次数: 0
[Biotherapies for juvenile idiopathic arthristis]. [青少年特发性关节炎的生物疗法]。
La Revue du praticien Pub Date : 2024-12-01
Florence A Aeschlimann, Pierre Quartier
{"title":"[Biotherapies for juvenile idiopathic arthristis].","authors":"Florence A Aeschlimann, Pierre Quartier","doi":"","DOIUrl":"","url":null,"abstract":"<p><p>BIOTHERAPIES FOR JUVENILE IDIOPATHIC ARTHRITIS. The introduction of biotherapies has dramatically changed the care and evolution of children with juvenile idiopathic arthritis. These biotherapies, directed against tumor necrosis factor (TNF) alpha, interleukine (IL)-1, IL-6, IL-17 or T cell costimulation (abatacept), and more recently small molecules, the Janus kinase (JAK) inhibitors, have significantly improved the outcomes of these patients. In addition, multiple biotherapies are currently evaluated in clinical trials. The overall safety profile of biotherapies in children is similar to adults; the most common adverse events are infections, dysimmune manifestations and allergic reactions. Up-to-date vaccination status is crucial to prevent treatment-associated complications. Children with juvenile idiopathic arthritis under biotherapy should be followed in specialised center, long-term follow-up regarding efficacy and pharmacovigilance is important.</p>","PeriodicalId":94123,"journal":{"name":"La Revue du praticien","volume":"74 10","pages":"1090-1096"},"PeriodicalIF":0.0,"publicationDate":"2024-12-01","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"","citationCount":null,"resultStr":null,"platform":"Semanticscholar","paperid":"144369903","PeriodicalName":null,"FirstCategoryId":null,"ListUrlMain":null,"RegionNum":0,"RegionCategory":"","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":"","EPubDate":null,"PubModel":null,"JCR":null,"JCRName":null,"Score":null,"Total":0}
引用次数: 0
[Epiglottitis in adults]. [成人会厌炎]。
La Revue du praticien Pub Date : 2024-12-01
Matthieu Bellakehal, Romain Montagnon
{"title":"[Epiglottitis in adults].","authors":"Matthieu Bellakehal, Romain Montagnon","doi":"","DOIUrl":"","url":null,"abstract":"","PeriodicalId":94123,"journal":{"name":"La Revue du praticien","volume":"74 10","pages":"1106"},"PeriodicalIF":0.0,"publicationDate":"2024-12-01","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"","citationCount":null,"resultStr":null,"platform":"Semanticscholar","paperid":"144369907","PeriodicalName":null,"FirstCategoryId":null,"ListUrlMain":null,"RegionNum":0,"RegionCategory":"","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":"","EPubDate":null,"PubModel":null,"JCR":null,"JCRName":null,"Score":null,"Total":0}
引用次数: 0
首页 上一页
0
×
引用
GB/T 7714-2015
复制
MLA
复制
APA
复制
导出至
BibTeX EndNote RefMan NoteFirst NoteExpress
×
提示
您的信息不完整，为了账户安全，请先补充。
现在去补充
×
提示
您因"违规操作"
具体请查看互助需知
我知道了
×
提示
现在去查看 取消
×
提示
确定
请完成安全验证×
相关产品
×
本文献相关产品
联系我们：info@booksci.cn Book学术提供免费学术资源搜索服务，方便国内外学者检索中英文文献。致力于提供最便捷和优质的服务体验。 Copyright © 2023 布克学术 All rights reserved.
京ICP备2023020795号-1
ghs 京公网安备 11010802042870号
Book学术文献互助
Book学术文献互助群
群 号：604180095
Book学术官方微信